-+ 0.00%
-+ 0.00%
-+ 0.00%

Goldman Sachs Maintains Buy on Olema Pharmaceuticals, Raises Price Target to $38

Benzinga·12/11/2025 17:27:35
語音播報
Goldman Sachs analyst Richard Law maintains Olema Pharmaceuticals (NASDAQ:OLMA) with a Buy and raises the price target from $26 to $38.